Medindia LOGIN REGISTER
Medindia
Advertisement

Neuralstem Reports First Quarter 2019 Fiscal Results

Wednesday, May 15, 2019 General News
Advertisement
- Kenneth C. Carter, PhD appointed Executive Chairman

Neuralstem, Inc.

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss

Three Months Ended March 31,

2019

2018

Revenues

$                              2,500

$                      2,500

Operating expenses:

Research and development expenses

1,514,463

1,169,441

General and administrative expenses

944,602

1,182,054

Total operating expenses

2,459,065

2,351,495

Operating loss

(2,456,565)

(2,348,995)

Other income (expense):

Interest income

29,000

17,749

Interest expense

(2,017)

(1,920)

Change in fair value of derivative instruments

(340,115)

190,219

Other income (expense)

(344,295)

(4,021)

Total other income (expense)

(657,427)

202,027

Net loss

$                      (3,113,992)

$             (2,146,968)

Net loss per share - basic and diluted

$                               (0.17)

$                      (0.14)

Weighted average common shares outstanding - basic

18,216,421

15,116,937

Comprehensive loss:

Net loss

$                      (3,113,992)

$             (2,146,968)

Foreign currency translation adjustment

(1,743)

115

Comprehensive loss

$                      (3,115,735)

$             (2,146,853)

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close